Novavax, Inc.
NVAX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.47B
Close$
$24.78
162.5% upside
Current Fair Value
162.5% upsideUndervalued by 162.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.47 Billion |
|---|---|
| Enterprise Value | $1.66 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.72 |
| Beta | 2.42 |
| Outstanding Shares | 164,574,000 |
Return
| Return on Equity | 129.90% |
|---|---|
| Return on Assets | -25.92% |
| Return on Invested Capital | -29.16% |
Valuation & Multiples
| P/E Ratio | -5.88 |
|---|---|
| PEG | 3.92 |
| Price to Sales | 4.72 |
| Price to Book Ratio | -4.72 |
| Enterprise Value to Revenue | 4.02 |
| Enterprise Value to EBIT | -9.12 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | -2.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.38
Average shareholder expectationRevenue Estimate
$52.51 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
$72.66 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.2184▼ 10.08% |
|---|---|
| Total Calls | 4,824,612▲ 23.41% |
| Total Puts | 5,878,200▲ 13.97% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 73.49%▲ 0.66% |
|---|---|
| Total Invested | $1.27B▲ 32.59% |
| Investors Holding | 296▲ 11.00% |
ESG Score
No data
About Novavax, Inc.
CEO: Stanley Erck